July 27, 2017 8:04 PM ET

Pharmaceuticals

Company Overview of Kalos Therapeutics, Inc.

Company Overview

Kalos Therapeutics, Inc. develops anti-proliferative drugs for the treatment of cancers and related co-morbidities. It offers KT-220, a drug for the treatment of human cancer cells in human pancreatic, breast, and lung cancers; KTV-111, an animal health drug that leverages the diuretic and therapeutic effects of new chemical entities; and KTH-222, a drug that regulates cell growth via inhibition of the mitogen-activated protein kinase pathway. The company was founded in 2005 and is based in San Diego, California.

4370 La Jolla Village Drive

Suite 400

San Diego, CA 92122

United States

Founded in 2005

Phone:

858-552-6890

Fax:

858-546-9227

Key Executives for Kalos Therapeutics, Inc.

Co-Founder, Chief Executive Officer and Director
President and Chief Medical Officer
Age: 65
Chief Scientific Officer of US Oncology
Age: 69
Chief Scientific Officer
Compensation as of Fiscal Year 2017.

Kalos Therapeutics, Inc. Key Developments

Kalos Therapeutics, Inc. Presents at White Hat Life Science Investor Conference, Sep-22-2016 09:30 AM

Kalos Therapeutics, Inc. Presents at White Hat Life Science Investor Conference, Sep-22-2016 09:30 AM. Venue: Phoenix, Arizona, United States.

Kalos Therapeutics, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 10:00 AM

Kalos Therapeutics, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 10:00 AM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States.

Kalos Therapeutics, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015

Kalos Therapeutics, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015 . Venue: Parc 55 Hotel, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kalos Therapeutics, Inc., please visit www.kalostpx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.